Kabir Nath was appointed CEO of Compass Pathways, and Justin Gover joined the company's Board of Directors.
8 reports, 2 independent
Updated Sep 9
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 8
- Developments
- 2
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kabir Nath was appointed CEO of Compass Pathways, and Justin Gover joined the company's Board of Directors.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Former CEO of GW Pharmaceuticals joined Compass Pathways Board.1 source
Kabir Nath appointed CEO of Compass Pathways; Justin Gover joined the Board.1 source
Keep exploring
The entities involved
-
Compass Pathways
mental health care company
Nothing else this week.
-
GW Pharmaceuticals
British biopharmaceutical company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Insider MonkeyCOMPASS Pathways Plc (CMPS)’ Psilocybin Therapy Hits Phase 3 Success in Depression We recently compiled a list of the 13 Best Psychedelic Stocks to Invest in Now. COMPASS Pathways Plc is one of them.
- Business WireCompass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights Positive primary endpoint achieved in first COMP360 Phase 3 trial with high statistical significance, clinical
- Business WireCompass Pathways Appoints Justin Gover to Board of Directors LONDON & NEW YORK, July 29, 2025--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating
- Unknown outlet